Evaxion Biotech showcases its AI-Immunology platform for vaccine discovery at R&D Day.

Evaxion Biotech hosts an R&D Day showcasing its AI-Immunology platform, a proprietary AI and machine learning technology that could revolutionize vaccine discovery, design, and development. The platform outperforms traditional methods, and its modular architecture makes it scalable and adaptable for partner needs. Evaxion's partnerships, including an ongoing vaccine collaboration with MSD, validate the platform's potential.

March 19, 2024
5 Articles